Citrus tamurana Hort. ex Tanaka (Hyuganatsu orange)‐derived arabinogalactan suppresses bone turnover in postmenopausal women: A randomized placebo‐controlled study
Journal of Obstetrics and Gynaecology Research · 2024
DOI: 10.1111/jog.16116 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2024. Verfasst von Masatoshi Yamaguchi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Miyazaki, Faculty of Medicine, Miyazaki, Japan. Hauptthemen laut MEDLINE: Galactans, Bone Remodeling, Postmenopause, Citrus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Aim
To evaluate Hyuganatsu oranges ( Citrus tamurana Hort. Ex Tanaka) derived arabinogalactan for bone turnover, we performed a randomized placebo‐controlled trial.
Methods
Sixty‐three postmenopausal women were age‐stratified and randomly assigned to receive arabinogalactan‐rich hyuganatsu juice (study group) or a placebo drink (control group) for 90 days. We measured blood tartrate‐resistant acid phosphatase 5b (TRACP5b), type I procollagen N‐terminal propeptide (P1NP), and other bone turnover biomarker levels at baseline, days 45 and 90 (T90) of the intervention, and day 30 of recovery. Cumulative effects were compared between groups using repeated‐measures linear mixed model analysis. The primary endpoint was the difference between the pre‐ and post‐intervention TRACP5b and P1NP levels.
Results
Using repeated measures linear mixed model analysis, the study group had significantly lower TRACP5b and P1NP levels at day 90 than the control group (mean [95% confidence interval]; TRACP5b: 310.0 [269.2–350.9] vs. 386.4 [341.2–431.6] mU/dL; P1NP: 53.7 [48.6–58.7] vs. 70.3 [64.1–76.4] ng/mL), whereas other biomarker levels showed no change.
Conclusion
Arabinogalactan‐rich Hyuganatsu juice suppressed bone mineral turnover and potentially improved ovarian hormone deficiency‐induced osteoporosis in postmenopausal women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Miyazaki, Faculty of Medicine, Miyazaki, Japan.
- Kitahara Clinic, Miyakonojo, Miyazaki, Japan.
- Department of Obstetrics and Gynecology, Kawakita General Hospital, Tokyo, Japan.
- Faculty of Biotechnology and Life Science, Sojo University, Kumamoto, Japan.
- Center for Collaborative Research & Community Cooperation, University of Miyazaki, Miyazaki, Japan.
- Faculty of Engineering, University of Miyazaki, University of Miyazaki, Miyazaki, Japan.
ORCID-Profile: Masatoshi Yamaguchi, Masanao Ohashi, Shoko Nishizono, Taichi Kobayashi, Munetoshi Miyatake, Hiroshi Sameshima
Zitieren
APA
Yamaguchi, M., Yoshiyama, T., Maruyama, R., Ohashi, M., Nishizono, S., Kobayashi, T., Miyatake, M., & Sameshima, H. (2024). Citrus tamurana Hort. ex Tanaka (Hyuganatsu orange)‐derived arabinogalactan suppresses bone turnover in postmenopausal women: A randomized placebo‐controlled study. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16116
Vancouver
Yamaguchi M, Yoshiyama T, Maruyama R, Ohashi M, Nishizono S, Kobayashi T, et al. Citrus tamurana Hort. ex Tanaka (Hyuganatsu orange)‐derived arabinogalactan suppresses bone turnover in postmenopausal women: A randomized placebo‐controlled study. Journal of Obstetrics and Gynaecology Research. 2024. doi:10.1111/jog.16116
BibTeX
@article{Yamaguchi2024,
author = {Yamaguchi, Masatoshi and Yoshiyama, Toshiko and Maruyama, Ruriko and Ohashi, Masanao and Nishizono, Shoko and Kobayashi, Taichi and Miyatake, Munetoshi and Sameshima, Hiroshi},
title = {Citrus tamurana Hort. ex Tanaka (Hyuganatsu orange)‐derived arabinogalactan suppresses bone turnover in postmenopausal women: A randomized placebo‐controlled study},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2024},
doi = {10.1111/jog.16116}
}
EUVIMED